The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

Buy-Rated Pozen Worth the Risks

 May 08, 2008 07:48 PM UTC
Return Risk
-13.51% MID
Tracked Blogger
Symbol Sentiment Start Return Closed
POZN Positive 05/08/08 -49.57% --

Graphic_arrow1 Via Zacks Analyst Blog:  

We expect the second quarter 2008 will be positive with respect to EPS and cash-flow based on the $20 million Glaxo milestone on the approval of Treximet.


 Graphic_website1 Read the rest of original post »



Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch